Phenobarbital-induced changes in NADPH-cytochrome c reductase and smooth endoplasmic reticulum in human liver
Authors:
- M. Michael ThalerMTM. Michael Thaler
- Peter R. DallmanPDPeter R. Dallman
- Joseph GoodmanJGJoseph Goodman
- 29 February 1972
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 80 (2) , 302-310
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The presence of a monooxygenase system in human fetal liver microsomesLife Sciences, 1970
- INFLUENCE OF ETHANOL AND MICROSOMAL DRUGS ON HEPATIC HEMODYNAMICS*Annals of the New York Academy of Sciences, 1970
- ETHANOL IN PREVENTION OF HYPERBILIRUBINÆMIA IN THE NEWBORNThe Lancet, 1969
- CONTROLLED TRIALS OF PHENOBARBITONE THERAPY IN NEONATAL JAUNDICEThe Lancet, 1969
- Hypertrophic, Hypoactive Smooth Endoplasmic Reticulum: A Sensitive Indicator of Hepatotoxicity Exemplified by DieldrinScience, 1968
- REDUCTION IN CONCENTRATION OF TOTAL SERUM-BILIRUBIN IN OFFSPRING OF WOMEN TREATED WITH PHENOBARBITONE DURING PREGNANCYThe Lancet, 1968
- REDUCTION OF SERUM-UNCONJUGATED-BILIRUBIN WITH PHENOBARBITONE IN ADULT CONGENITAL NON-HÆMOLYTIC UNCONJUGATED HYPERBILIRUBINÆMIAThe Lancet, 1968
- Ultrastructural Studies in Alcoholic Liver DiseaseDigestion, 1968
- INCREASE IN LEVELS OF GLUCURONYLATING ENZYMES AND ASSOCIATED RISE IN ACTIVITIES OF MITOCHONDRIAL OXIDATIVE ENZYMES UPON PHENOBARBITAL ADMINISTRATION IN THE RATJournal of Cell Biology, 1967
- Drug-Induced Changes in the Liver Endoplasmic Reticulum: Association with Drug-Metabolizing EnzymesScience, 1963